Page 105 - GTM-3-1

Global Translational Medicine Anergy in Leishmania-associated malignancy

doi: 10.12816/0006420 doi: 10.1016/s0065-230x(02)84008-8
10. Armengot-Carbó M, Carmena-Ramón R, Rodrigo- 14. Christopoulos P, Dopfer EP, Malkovsky M, et al. A novel
Nicolás B, Ferrando-Marco J. Unsuspected visceral thymoma-associated immunodeficiency with increased
leishmaniasis infiltrating a squamous cell carcinoma. Actas naive T cells and reduced CD247 expression. J Immunol.
Dermosifiliogr. 2012;103(4):321-323. 2015;194(7):3045-3053.
doi: 10.1016/j.ad.2011.04.016 doi: 10.4049/jimmunol.1402805
11. Ouattassi N, Titou A, Hammas N, Kamal D, El Amine El 15. Friedman R, Hanson S, Goldberg LH. Squamous cell
Alami MN. Squamous cell carcinoma associated with carcinoma arising in a Leishmania scar. Dermatol Surg.
an active cutaneous leishmaniasis in immunocompetent 2003;29(11):1148-1149.
patient: Case presentation of an unlikely association and doi: 10.1046/j.1524-4725.2003.29354.x
literature-review. Egypt J Otolaryngol. 2022;38:148.
16. Sinha S, Fernández G, Kapila R, Lambert WC, Schwartz RA.
doi: 10.1186/s43163-022-00335-6 Diffuse cutaneous leishmaniasis associated with the immune
12. Kopterides P, Mourtzoukou EG, Skopelitis E, Tsavaris N, reconstitution inflammatory syndrome. Int J Dermatol.
Falagas ME. Aspects of the association between 2008;47(12):1263-1270.
leishmaniasis and malignant disorders. Trans R Soc Trop doi: 10.1111/j.1365-4632.2008.03804.x
Med Hyg. 2007;101(12):1181-1189.
17. França-Costa J, Van Weyenbergh J, Boaventura VS, et al.
doi: 10.1016/j.trstmh.2007.08.003 Arginase I, polyamine, and prostaglandin E2 pathways
suppress the inflammatory response and contribute to diffuse
13. Dalgleish AG, O’Byrne KJ. Chronic immune activation and
inflammation in the pathogenesis of AIDS and cancer. Adv cutaneous leishmaniasis. J Infect Dis. 2015;211(3):426-435.
Cancer Res. 2002;84:231-276. doi: 10.1093/infdis/jiu455

Volume 3 Issue 1 (2024) 5 https://doi.org/10.36922/gtm.2281